+1.2108032709

Interfector Therapeutics

Interfector TherapeuticsInterfector TherapeuticsInterfector Therapeutics

Interfector Therapeutics

Interfector TherapeuticsInterfector TherapeuticsInterfector Therapeutics

+1.2108032709

Innovative Biotechnology Solutions

Innovative Biotechnology SolutionsInnovative Biotechnology Solutions
Learn About Our Research

About US

Our Mission

At Interfector Therapeutics, our mission is to pioneer transformative therapies that address unmet needs in oncology and enhance patients’ quality of life.
We are committed to advancing scientific frontiers through the discovery and development of novel, first-in-class investigational agents targeting critical pathways in cancer biology.

WELCOME TO INTERFECTOR THERAPEUTICS

We redefine the future of cancer care.

With over five decades of combined expertise in medicine and drug discovery, our team is driven by innovation, precision, and patient-centered purpose. We aim to transform promising molecular discoveries into groundbreaking therapeutics that improve survival and extend healthy lifespan.

Discover our pipeline

MEET THE TEAM

Our multidisciplinary team unites leaders in oncology, translational research, pharmaceutical development, and biotechnology entrepreneurship. Together, we are committed to accelerating the transition from discovery to clinic, with a shared vision of delivering curative outcomes for patients worldwide.

Find out more

Frequently Asked Questions

Please reach us at info@interfectortherapeutics.com if you cannot find an answer to your question.

Founded in 2024, Interfector Therapeutics emerged from a strategic collaboration between Dr. Daruka Mahadevan and Dr. Eloïse Dray, along with their expert network of scientific and clinical collaborators. Fueled by a common mission to address urgent unmet needs in advanced cancers, Interfector Therapeutics unifies a robust drug development pipeline and multidisciplinary expertise to deliver hope through innovation.


We are developing anti-cancer drugs to address unmet needs. Our research and development programs focus on:

  • Epithelial Carcinomas – including breast, lung, and gastrointestinal malignancies.
     
  • Hematologic Malignancies – encompassing B-cell and T-cell lymphomas and leukemias.


Discover what makes us special

Contact Us

Better yet, see us in person!

We love to interact, so please email to schedule a visit during normal business hours.

Interfector Therapeutics

7703 Floyd Curl Drive, San Antonio, TX, USA

+1.2108032709

Hours

Open today

09:00 am – 05:00 pm

Drop us a line!

Attach Files
Attachments (0)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Subscribe

Interfector Therapeutics

7703 Floyd Curl Drive, San Antonio, TX, USA

+1.2108032709

Copyright © 2025 Interfector Therapeutics - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept